FDA adds Protégé to list of approved iliac stents

Candace Stuart | | Cardiovascular Business | Vascular & Endovascular

The FDA approved a self-expanding stent system for patients with peripheral artery disease, adding another option for treating blockages in the iliac arteries.

Medtronic received the all-clear to market its Protégé GPS self-expanding peripheral stent system as a treatment for stenotic lesions of the common and external iliac arteries. The agency based its approval on the nonrandomized DURABILITY trial, which showed a 95.8 percent patency rate, according to Medtronic.

The system incorporates a self-expanding nitinol stent with GPS markers at the proximal and distal ends that are designed to facilitate positioning. The Protégé device is compatible with a 6 French profile delivery system.

Candace Stuart, Contributor

Related Content

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Advancing AI for vascular surgery will require a commitment to data integrity
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Genetic predisposition to depression increases CVD risk in women, but not men
Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups
IVUS-guided PCI reduces risks in patients with diabetes

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.